Auris Medical Stock Forecast, Price & News

Auris Medical (NASDAQ:EARS) Frequently Asked Questions

What stocks does MarketBeat like better than Auris Medical?

Wall Street analysts have given Auris Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Auris Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Auris Medical's earnings last quarter?

Auris Medical Holding Ltd. (NASDAQ:EARS) released its quarterly earnings results on Thursday, May, 11th. The biotechnology company reported ($4.40) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($2.80) by $1.60.
View Auris Medical's earnings history.

When did Auris Medical's stock split? How did Auris Medical's stock split work?

Shares of Auris Medical reverse split on Wednesday, May 1st 2019. The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 30th 2019. An investor that had 100 shares of Auris Medical stock prior to the reverse split would have 5 shares after the split.

Who are Auris Medical's key executives?

Auris Medical's management team includes the following people:

• Thomas Meyer, Chairman & Chief Executive Officer
• Elmar Schärli, Chief Financial Officer
• Samuel A. Wickline, Chief Scientific Officer
• Andrea Vondraskova, Medical Director

Who are some of Auris Medical's key competitors?

Some companies that are related to Auris Medical include Biophytis (BPTS), Galecto (GLTO), Eledon Pharmaceuticals (ELDN), LifeVantage (LFVN), Agile Therapeutics (AGRX), Ocuphire Pharma (OCUP), Lumos Pharma (LUMO), Gain Therapeutics (GANX), Aptorum Group (APM), Helix BioPharma (HBPCF), Celsion (CLSN), NeuroBo Pharmaceuticals (NRBO), OncoSec Medical (ONCS), Moleculin Biotech (MBRX) and Stealth BioTherapeutics (MITO).
View all of EARS's competitors.

What other stocks do shareholders of Auris Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Auris Medical investors own include Helios and Matheson Analytics (HMNY), TransEnterix (TRXC), Anavex Life Sciences (AVXL), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Flexion Therapeutics (FLXN), Novavax (NVAX), Iconix Brand Group (ICON), Onconova Therapeutics (ONTX) and Nabriva Therapeutics (NBRV).

What is Auris Medical's stock symbol?

Auris Medical trades on the NASDAQ under the ticker symbol "EARS."

Who are Auris Medical's major shareholders?

Auris Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Ikarian Capital LLC (3.54%), Susquehanna International Group LLP (0.00%), Group One Trading L.P. (0.00%), Simplex Trading LLC (0.00%), Citadel Advisors LLC (0.00%) and Squarepoint Ops LLC (0.09%).

Which institutional investors are selling Auris Medical stock?

EARS stock was sold by a variety of institutional investors in the last quarter, including Ikarian Capital LLC, and Citadel Advisors LLC.

Which institutional investors are buying Auris Medical stock?

EARS stock was acquired by a variety of institutional investors in the last quarter, including Simplex Trading LLC, Group One Trading L.P., Squarepoint Ops LLC, Wells Fargo & Company MN, Cutler Group LP, and Susquehanna International Group LLP.

What is Auris Medical's stock price today?

One share of EARS stock can currently be purchased for approximately $2.15.

How much money does Auris Medical make?

Auris Medical has a market capitalization of $24.55 million.

How many employees does Auris Medical have?

Auris Medical employs 132,200 workers across the globe.

What is Auris Medical's official website?

The official website for Auris Medical is www.aurismedical.com.

Where are Auris Medical's headquarters?

Auris Medical is headquartered at Clarendon House 2 Church Street, Hamilton D0, HM 11.

How can I contact Auris Medical?

Auris Medical's mailing address is Clarendon House 2 Church Street, Hamilton D0, HM 11. The biotechnology company can be reached via phone at (441) 295-5950 or via email at [email protected].